Non-deletion 5q
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients (NCT00699842) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2008-07-01 |
Track Non-deletion 5q automatically
Every clearance here is in the API, with alerts when new ones post.